SCIENTIFIC HUB

Follow the evidence.

187.286 articles found

Open access

Evaluation of c-Abl inhibitor vodobatinib in subjects with early Parkinson's disease: a phase 2, randomized, double-blind, placebo-controlled study.

Sarva H, Pahwa R, Hernandez-Vara J, Goldstein MA, Borgohain R, Factor SA, Inamdar S, Love D, Hames C, Fu Y, Mergel V, Goldfine A, Kumar C, Piccoli SP, Yao SL, Hurko O.

NPJ Parkinsons Dis · 2026-02-03

DOI: 10.1038/s41531-026-01275-1PMID: 41634026

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Ginsenoside Rg1 as a Multifunctional Therapeutic Agent: Pharmacological Properties, Molecular Mechanisms and Clinical Perspectives in Complementary Medicine.

Cortés H, Lima E, Duarte-Peña L, Peña-Corona SI, Almarhoon ZM, Kaverikana R, Mangalpady SS, Shet VB, Manjeshwar N, Sharifi-Rad J, Chen JT, Leyva-Gómez G, Setzer WN, Calina D.

Food Sci Nutr · 2026-02-03

DOI: 10.1002/fsn3.71486PMID: 41648642

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.